Berkshire Sterile Manufacturing to Host Webinar on Formulation Development for First-in-Human Studies
Globe Newswire Berkshire Sterile Manufacturing (BSM) is pleased to announce their ninth webinar in their webinar series, Sterile Filling 101, which will be held on Wednesday, September 13 at 1PM EST.…
Overcoming Common Challenges in Fill Finish for Monoclonal Antibodies (mAbs)
Monoclonal antibodies (or mAbs) are class of therapeutic proteins designed to target specific molecules or cells in the body. They are used in treating cancer, autoimmune disorders, and infectious diseases,…
Optimizing Oligonucleotide Drug Products: Strategies for Formulation, Lyophilization, and Fill Finish Processes
Imagine if you could create a targeted, highly effective, and life-saving treatment to a disease once thought untreatable and incurable with few to no side effects. That is what the…
From Bench to Bedside: The Journey of Oligonucleotide Drug Development and Sterile Filling
Go to downloads page About this white paper: This white paper serves as a comprehensive guide to enhancing the formulation, lyo cycle development, and fill finish process of oligonucleotide therapeutics.…
Berkshire Sterile to offer formulation, lyophilization, and method development services
Globe Newswire Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions.…
